BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11585054)

  • 1. Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.
    Mishra M; Porter-Kelley JM; Singh PK; Bennett JR; Chaudhuri G
    Biochem Pharmacol; 2001 Sep; 62(5):569-80. PubMed ID: 11585054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.
    Mishra M; Bennett JR; Chaudhuri G
    Biochem Pharmacol; 2001 Feb; 61(4):467-76. PubMed ID: 11226381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite.
    Chaudhuri G
    Biochem Pharmacol; 1997 Feb; 53(3):385-91. PubMed ID: 9065742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
    Lang T; Goyard S; Lebastard M; Milon G
    Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.
    Khouri R; Novais F; Santana G; de Oliveira CI; Vannier dos Santos MA; Barral A; Barral-Netto M; Van Weyenbergh J
    PLoS One; 2010 Dec; 5(12):e14394. PubMed ID: 21200432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
    Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
    Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.
    Seay MB; Heard PL; Chaudhuri G
    Infect Immun; 1996 Dec; 64(12):5129-37. PubMed ID: 8945556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis.
    Aoki JI; Muxel SM; Zampieri RA; Acuña SM; Fernandes JCR; Vanderlinde RH; Sales MCOP; Floeter-Winter LM
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006025. PubMed ID: 29073150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stachytarpheta cayennensis extract inhibits promastigote and amastigote growth in Leishmania amazonensis via parasite arginase inhibition.
    Maquiaveli CDC; Oliveira E Sá AM; Vieira PC; da Silva ER
    J Ethnopharmacol; 2016 Nov; 192():108-113. PubMed ID: 27432217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
    Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultivation and characterization of stable Leishmania guyanensis complex axenic amastigotes derived from infected U937 cells.
    Puentes F; Diaz D; Hoya RD; Gutíerrez JA; Lozano JM; Patarroyo ME; Moreno A
    Am J Trop Med Hyg; 2000; 63(1-2):102-10. PubMed ID: 11357988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.
    Ramazeilles C; Mishra RK; Moreau S; Pascolo E; Toulmé JJ
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7859-63. PubMed ID: 8058724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destruction of Leishmania mexicana amazonensis amastigotes within macrophages in culture by phenazine methosulfate and other electron carriers.
    Rabinovitch M; Dedet JP; Ryter A; Robineaux R; Topper G; Brunet E
    J Exp Med; 1982 Feb; 155(2):415-31. PubMed ID: 7057140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
    Aulner N; Danckaert A; Rouault-Hardoin E; Desrivot J; Helynck O; Commere PH; Munier-Lehmann H; Späth GF; Shorte SL; Milon G; Prina E
    PLoS Negl Trop Dis; 2013; 7(4):e2154. PubMed ID: 23593521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destruction of Leishmania mexicana amazonensis amastigotes within macrophages by lysosomotropic amino acid esters.
    Rabinovitch M; Zilberfarb V; Ramazeilles C
    J Exp Med; 1986 Mar; 163(3):520-35. PubMed ID: 3950542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of promastigotes and intracellular amastigotes from distinct Leishmania species to the calpain inhibitor MDL28170.
    de Sousa Araújo PS; de Oliveira SSC; d'Avila-Levy CM; Dos Santos ALS; Branquinha MH
    Parasitol Res; 2018 Jul; 117(7):2085-2094. PubMed ID: 29728827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide.
    Khan I; Al-Awadi FM; Thomas N
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):199-207. PubMed ID: 11572597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.